Taken together, our findings indicate that CAV2 promotes HNSCC invasion and metastasis by regulating the expression of S100 proteins, presenting a novel potential target for anticancer therapy in HNSCC. This evidence concerns the gene CAV2 and head and neck squamous cell carcinoma.